Skip to main content
. 2021 Jan;24(1):116–122. doi: 10.22038/ijbms.2020.49486.11313

Figure 3.

The serum anti-tetanus toxoid (TT) immunoglobulin G titers of immunized rabbits with different vaccine formulations by nasal administration. Animals were inoculated at days 0, 14, and 28 with one of the following formulations: TT solution; trimethyl chitosan (TMC) containing TT+cross-linked dextran microspheres (CDM); and TMC (TT)+Lactose (Lac). The intramuscular injection of Alum TT was administrated as a positive control. At days 42, sera were collected to identify the IgG titers by end-point titration using the ELISA technique. Results present the mean±SD (n=4)

Figure 3

*Significant difference between TT solution and test groups *(P<0.05), **(P<0.01), and ***(P<0.001)